Lorcaserin Extended-Release Tablets and Von Willebrand Factor
Determining the interaction of Lorcaserin Extended-Release Tablets and Von Willebrand Factor and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: antihemophilic factor / von willebrand factor
Brand name: Alphanate, Humate-P, Wilate, Wilstart, Dried Factor VIII Fraction Type 8Y, Haemate P, Optivate
Synonyms: Antihemophilic and von Willebrand factor complex, Antihemophilic Factor/von Willebrand Factor Complex (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Von Willebrand factor recombinant
- Lorcaserin Extended-Release Tablets-Von willebrand factor recombinant Intravenous
- Lorcaserin Extended-Release Tablets-Vonvendi
- Lorcaserin Extended-Release Tablets-Vopac
- Lorcaserin Extended-Release Tablets-Vopac MDS
- Lorcaserin Extended-Release Tablets-Vorapaxar
- Von Willebrand Factor-Lorcaserin Hydrochloride
- Von Willebrand Factor-Lorcaserin Tablets
- Von Willebrand Factor-Lorcet
- Von Willebrand Factor-Lorcet Plus
- Von Willebrand Factor-Lorcet Tablets
- Von Willebrand Factor-Lorlatinib